BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

£32.975
FREE Shipping

BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

RRP: £65.95
Price: £32.975
£32.975 FREE Shipping

In stock

We accept the following payment methods

Description

Management of iron deficiency anaemia, including update to oral iron dosing and monitoring based on British Society of Gastroenterology guidelines The cover image preview of BNF 84 (British National Formulary) September 2022 – March 2023 PDF Looks Something like this: Ibrutinib (Imbruvica®): new risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac events

Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017) The interactions are displaying correctly when the interactions information is accessed directly via links from the Interactions section of the co-drug monographs in BNF and BNF for Children. From June 2023, BNF Publications will be more clearly and consistently identifying specialist drug monographs within content, by including the words “Specialist drug” alongside the monograph title. This feature will be applied to existing monographs, and to monographs moving forward, that are used within specialist settings (such as drugs used for malignancy, and those given via intravitreal injection). These “specialist drug” monographs will contain less detail than a regular monograph within BNF Publications. A “specialist drug” monograph will continue to include information to support patient safety and non-specialist patient care (such as important safety information, interactions, side-effects, and contra-indications), but it will not contain information which is within the remit of specialist care (such as doses, and directions for administration). Based on the primary use case of BNF Publications, supporting non-specialist clinical practice, the preface of the BNF sets out that less detail is given for specialist areas such as malignant disease. However, there has been no consistent style used within BNF monographs to highlight to users that a drug is used in these specialist areas.

You may also like…

Over the last year, we have undertaken research to understand how we could ensure that specialist drug content in BNF Publications is aligned with the stated scope within the preface, and with the primary use case of the BNF. Analytics around the use of BNF Publications’ content confirmed that specialist drug content is accessed much less frequently than drug content for non-specialist use. User research supported the analytics, and showed that those users who did access specialist content were most commonly looking at safety information, such as contra-indications, interactions, and side-effects. For each vaccine monograph, the Drug action section includes a short summary of the vaccine type. Detailed information on the vaccine’s mechanism of action can be found in the corresponding Treatment summaries. The classifications, which are used to group similar vaccines, have also been updated. Author (Year of publication) 'Title of chapter/section', in Title of reference source.Available at: URL (Accessed: date). The British National Formulary (BNF) is a book that is published twice a year in March and September. Compiled with the advice of clinical experts, its an essential reference providing up to date guidance on the prescribing, dispensing and administration of medicines. British National Formulary (BNF) Product Details: Blood Results in Clinical Practice: A Practical Guide to Interpreting Blood Test Results - 2nd ed. (2019)

We may be able to source and supply a paper copy in exceptional circumstances, from surplus BNFs distributed to other parts of the NHS. Please register your interest in receiving a copy via the online form at: https://www.snapsurveys.com/wh/s.asp?k=153553886772 Biologics, Biosimilars and Biobetters: An Introduction for Pharmacists, Physicians and other Health Practitioners(2021)Ideal for use by Pharmacists, Chemists, Nurses and Doctors within Hospitals, Nursing Homes, Pharmacies and Hospices and the ideal reference tool for all Care and support staff. See also: Pharmaceutical Preformulation and Formulation: a Practical Guide from Candidate Drug Selection to Commercial Dosage Form - 2nd ed. (2009)



  • Fruugo ID: 258392218-563234582
  • EAN: 764486781913
  • Sold by: Fruugo

Delivery & Returns

Fruugo

Address: UK
All products: Visit Fruugo Shop